For: | Dusheiko GM, Jacobs MG. Perspectives on the management of chronic hepatitis B and C. Expert Review of Anti-infective Therapy 2014;7:243-7. [DOI: 10.1586/eri.09.16] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis] |
---|
Number | Citing Articles |
1 | Tanwar S, Trembling PM, Dusheiko GM. TMC435 for the treatment of chronic hepatitis C. Expert Opin Investig Drugs. 2012;21:1193-1209. [PMID: 22616626 DOI: 10.1517/13543784.2012.690392] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis] |
2 | Trembling PM, Tanwar S, Dusheiko GM. Boceprevir: an oral protease inhibitor for the treatment of chronic HCV infection. Expert Rev Anti Infect Ther 2012;10:269-79. [PMID: 22397560 DOI: 10.1586/eri.12.8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis] |